Clinical Trials Directory

Trials / Completed

CompletedNCT04204954

Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery

A Randomized Controlled Trial of Treatment Efficacy in Ameliorating Demodex Spp. Infestation Among Cases Undergoing Cataract Surgery

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Hospital de La Luz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Demodex blepharitis is a prevalent cause of comorbid infection among individuals undergoing cataract surgery. Several complications may arise in the postsurgical period from Staphylococcus or Streptococcus co-infections, as Demodex is a vector for these pathogens. Hence, prophylactic treatments before cataract surgery may lead to a reduction in complication rates. Since Demodex infestation and cataract surgery are two prevalent coexisting conditions in the general population, this study aims to test the effect of four combined treatments to eradicate or improve the Demodex infestation index before surgery. The investigators are conducting a single-blinded randomized trial of four therapies in participants undergoing cataract surgery. All participants will or are receiving daily eyelid cleansing bid and topical 0.3% ciprofloxacin q4h for three days added to the allocated treatment arm. Our four intervention groups are: \[1\] Blephaclean eye scrubs; \[2\] 50% dilution baby shampoo; \[3\] tea tree oil shampoo; \[4\]: topical 0.3% ciprofloxacin alone. To assess treatment efficacy, the investigators will perform eyelash hair epilation pre and postoperatively. The primary outcome is a change in the mean Demodex spp. infestation index. Also, a change in the crude number of Demodex (egg, larvae, nymph, or adult-form) spp. in eyelashes after one-week of therapy.

Conditions

Interventions

TypeNameDescription
OTHERTea Tree Oil ShampooTwice a day eyelid margin cleansing for three days.
DRUGCiprofloxacin Ophthalmic Ointment 0.3%Applied topically in the eyelid margin every four hours for three days.
OTHERBaby shampooTwice a day eyelid margin cleansing for three days.
OTHERBlephacleanTwice a day eyelid margin cleansing for three days.

Timeline

Start date
2019-05-06
Primary completion
2019-11-14
Completion
2019-12-13
First posted
2019-12-19
Last updated
2020-04-27

Locations

1 site across 1 country: Mexico

Regulatory

Source: ClinicalTrials.gov record NCT04204954. Inclusion in this directory is not an endorsement.